Loading provider…
Loading provider…
Surgery Physician in Vacaville, CA
NPI: 1184981821Primary Practice Location
KAISER FOUNDATION HOSPITAL - VACAVILLE
1 Quality Dr, Vacaville, CA
Primary Employer
Permanente Medical Group Inc
northerncalifornia.permanente.org
HQ Phone
Get M.D. George's Phone Numberphone_androidMobile
Get M.D. George's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
CA State Medical License
CA State Medical License
2017 - 2026
TX State Medical License
2012 - 2026

American Board of Surgery
Surgery

American Board of Surgery
Surgical Critical Care
University of Texas Health Science Center at Houston
Residency • Surgery
2010 - 2017
Rutgers Robert Wood Johnson Medical School
Medical School
Until 2010
University of Pennsylvania
MB • Biomedical Sciences
1999 - 2003
Biotechnology
2003 - 2004
Cedars-Sinai Medical Center
Fellowship • Surgical Critical Care
2017 - 2018
Off-pump revascularization for significant left ventricular dysfunction.
Authors: Yi-Ping Woo
Journal: Asian Cardiovasc Thorac Ann
Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin A2.
Authors: Richard Cheng, Richard Cheng, Erik Suarez, Yi-Ping Woo
Journal: J Thorac Cardiovasc Surg
Publication Date: 2007-02-22
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells.
Authors: Benjamin Aertker, Margaret Jackson, Charles Cox, Ryan Kitagawa, Sean Savitz
Publication Date: 2016-08-01
Lead Sponsor: The University of Texas Health Science Center, Houston
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Intervention / Treatment: BIOLOGICAL: autologous bone marrow mononuclear cells, OTHER: Placebo Infusion
Lead Sponsor: The University of Texas Health Science Center, Houston
Intervention / Treatment: BIOLOGICAL: autologous bone marrow mononuclear cells
Lead Sponsor: The University of Texas Health Science Center, Houston
Intervention / Treatment: DRUG: Autologous bone marrow precursor cell harvest and transplant